Reneo Pharmaceuticals RPHM Stock
Reneo Pharmaceuticals Price Chart
Reneo Pharmaceuticals RPHM Financial and Trading Overview
| Reneo Pharmaceuticals stock price | 1.73 USD |
| Previous Close | 7.42 USD |
| Open | 7.33 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 7.04 - 8.02 USD |
| 52 Week Range | 1.79 - 11.3 USD |
| Volume | 141.77K USD |
| Avg. Volume | 112.26K USD |
| Market Cap | 241.66M USD |
| Beta (5Y Monthly) | 1.241746 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.52 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.33 USD |
RPHM Valuation Measures
| Enterprise Value | 157.28M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.4519231 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.0703576 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.767 |
Trading Information
Reneo Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.241746 |
| 52-Week Change | 245.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.3 USD |
| 52 Week Low | 1.79 USD |
| 50-Day Moving Average | 8.37 USD |
| 200-Day Moving Average | 4.53 USD |
RPHM Share Statistics
| Avg. Volume (3 month) | 112.26K USD |
| Avg. Daily Volume (10-Days) | 125.38K USD |
| Shares Outstanding | 33.66M |
| Float | 17.47M |
| Short Ratio | 3.56 |
| % Held by Insiders | 3.17% |
| % Held by Institutions | 73.80% |
| Shares Short | 555.22K |
| Short % of Float | 2.74% |
| Short % of Shares Outstanding | 1.65% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.26% |
| Return on Equity (ttm) | -48.58% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -56846000 USD |
| Net Income Avi to Common (ttm) | -54026000 USD |
| Diluted EPS (ttm) | -1.85 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 93.79M USD |
| Total Cash Per Share (mrq) | 2.79 USD |
| Total Debt (mrq) | 1.34M USD |
| Total Debt/Equity (mrq) | 1.54 USD |
| Current Ratio (mrq) | 9.257 |
| Book Value Per Share (mrq) | 3.468 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -47411000 USD |
| Levered Free Cash Flow (ttm) | -28104500 USD |
Profile of Reneo Pharmaceuticals
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 18575 Jamboree Road |
| ZIP | 92612 |
| Phone | 858 283 0280 |
| Website | https://reneopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 48 |
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.
Q&A For Reneo Pharmaceuticals Stock
What is a current RPHM stock price?
Reneo Pharmaceuticals RPHM stock price today per share is 1.73 USD.
How to purchase Reneo Pharmaceuticals stock?
You can buy RPHM shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Reneo Pharmaceuticals?
The stock symbol or ticker of Reneo Pharmaceuticals is RPHM.
Which industry does the Reneo Pharmaceuticals company belong to?
The Reneo Pharmaceuticals industry is Biotechnology.
How many shares does Reneo Pharmaceuticals have in circulation?
The max supply of Reneo Pharmaceuticals shares is 33.42M.
What is Reneo Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Reneo Pharmaceuticals PE Ratio is now.
What was Reneo Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Reneo Pharmaceuticals EPS is -2.52 USD over the trailing 12 months.
Which sector does the Reneo Pharmaceuticals company belong to?
The Reneo Pharmaceuticals sector is Healthcare.
Reneo Pharmaceuticals RPHM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}